For the full year 2023, Option Care Health expects to generate: Net Revenue of $4.2 billion to $4.3 billion; Adjusted EBITDA of $415 million to $425 million; Cash Flow from Operations of at least $350 million, inclusive of Amedisys termination fee, net of expenses; Additionally, the Company continues to anticipate an effective tax rate of 27% to 29% and net interest expense of approximately $55.0 million to $59.0 million.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on OPCH:
- Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2023
- OPCH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Option Care Health management to meet with William Blair
- Option Care Health to Announce Second Quarter 2023 Financial Results and Host Conference Call
- Amedisys downgraded to Hold from Buy at Benchmark